4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001995218-26-000004
Chief Executive Officer sold 10,173 shares at $6.38 ($64,924)
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Sale : show line 1 in the form | −10,173 | $6.38 | $64,924 | 392,483 | D |
| Open-market sales · 10,173 sh · avg $6.38 · $64,924 | ||||||
Loading xslF345X05/form4-02202026_050203.xml…